Peter Graham has served as ADC Therapeutics' Chief Legal and Compliance Officer and Secretary since March 2024, having previously served as Chief Legal Officer and Secretary since November 2022. From 2015 until its sale to Halozyme Therapeutics in 2022 he served as Executive Vice President, General Counsel, Chief Compliance Officer, Human Resources and Secretary of Antares Pharma, and from 2010 to 2015 as Executive Vice President, General Counsel, Chief Compliance Officer and Global Human Resources at Delcath Systems; he earlier held senior legal and compliance roles at ACIST Medical Systems, E-Z-EM and AngioDynamics. Mr. Graham received his J.D. from Yeshiva University's Benjamin N. Cardozo School of Law and his B.A. in Political Science from the University of Wisconsin-Madison.